Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts

Neuromuscular Disorders

Volumn 19, Issue 11, 2009, Pages 766-772

  Vesa, Jouni ^a   Su, Hailing ^a   Watts, Giles D ^b   Krause, Sabine ^c   Walter, Maggie C ^c   Martin, Barbara ^d   Smith, Charles ^d   Wallace, Douglas C ^a,e   Kimonis, Virginia E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Frontotemporal dementia; IBMPFD; Inclusion body myopathy; Myoblasts; Paget's disease of the bone; Vacuoles; VCP (valosin containing protein)

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; VALOSIN CONTAINING PROTEIN;

ADULT; APOPTOSIS; ARTICLE; AUTOPHAGY; BONE REMODELING; CASE REPORT; CELL CULTURE; CELL FUSION; CELL VACUOLE; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCLUSION BODY MYOSITIS; MALE; MUSCLE CELL; MUSCLE WEAKNESS; MYOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION;

ADENOSINE TRIPHOSPHATASES; ADULT; APOPTOSIS; AUTOPHAGY; CASPASE 3; CELL CYCLE PROTEINS; CELL FUSION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; IN SITU NICK-END LABELING; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MUTATION; MYOBLASTS; MYOSITIS, INCLUSION BODY; OSTEITIS DEFORMANS;

EID: 70350046244     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.08.003     Document Type: Article

References (40)

1. Kimonis V.E., Kovach M.J., Waggoner B., et al. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med 2 (2000) 232-241
2. Kimonis V.E., Mehta S.G., Fulchiero E.C., et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A146 (2008) 745-757
3. Weihl C.C., Temiz P., Miller S.E., et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79 (2008) 1186-1189
4. Miller B.L., Ikonte C., Ponton M., et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 48 (1997) 937-942
5. Mehta S.G., Watts G.D., Adamson J.L., et al. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genet Med 9 (2007) 9-13
6. Watts G.D., Wymer J., Kovach M.J., et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36 (2004) 377-381
7. Wang Q., Song C., and Li C.C. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol 146 (2004) 44-57
8. Braun R.J., and Zischka H. Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim Biophys Acta 1783 (2008) 1418-1435
9. Rabouille C., Kondo H., Newman R., Hui N., Freemont P., and Warren G. Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell 92 (1998) 603-610
10. Rabinovich E., Kerem A., Frohlich K.U., Diamant N., and Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 22 (2002) 626-634
11. Jarosch E., Geiss-Friedlander R., Meusser B., Walter J., and Sommer T. Protein dislocation from the endoplasmic reticulum - pulling out the suspect. Traffic 3 (2002) 530-536
12. Kondo H., Rabouille C., Newman R., et al. P47 is a cofactor for p97-mediated membrane fusion. Nature 388 (1997) 75-78
13. Meyer H.H., Shorter J.G., Seemann J., Pappin D., and Warren G. A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J 19 (2000) 2181-2192
14. Dai R.M., and Li C.C. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 3 (2001) 740-744
15. Rape M., Hoppe T., Gorr T., Kalocay M., Richly H., and Jentsch J. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107 (2001) 667-677
16. Weihl C.C., Dalal S., Pestronk A., and Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum Mol Genet 15 (2006) 189-199
17. Kakizuka A. Roles of VCP in human neurodegenerative disorders. Biochem Soc Trans 36 (2008) 105-108
18. Bechet D., Tassa A., Taillandier D., Combaret L., and Attaix D. Lysosomal proteolysis in skeletal muscle. Int J Biochem Cell Biol 37 (2005) 2098-2114
19. Malicdan M.C., Noguchi S., Nonaka I., Saftig P., and Nishino I. Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 18 (2008) 521-529
20. Klionsky D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev 8 (2007) 931-937
21. Kimonis V, Watts G. Inclusion body myopathy associated with paget disease of bone and/or frontotemporal dementia. GeneTests (www.genetests.org) and University of Washington, Seattle; 2007.
22. Kimonis V.E., Fulchiero E., Vesa J., and Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta 1782 (2008) 744-748
23. Muller J.M., Deinhardt K., Rosewell I., Warren G., and Shima D.T. Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem Biophys Res Commun 354 (2007) 459-465
24. Weihl C.C., Miller S.E., Hanson P.I., and Pestronk A. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum Mol Genet 16 (2007) 919-928
25. Hirabayashi M., Inoue K., Tanaka K., et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 8 (2001) 977-984
26. Lobrinus J.A., Schorderet D.F., Payot M., et al. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease). Neuromuscul Disord 15 (2005) 293-298
27. Danon M.J., Oh S.J., DiMauro S., et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology 31 (1981) 51-57
28. Nishino I., Fu J., Tanji K., et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 406 (2000) 906-910
29. Sugie K., Noguchi S., Kozuka Y., et al. Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol 64 (2005) 513-522
30. Horsley V., and Pavlath G.K. Forming a multinucleated cell: molecules that regulate myoblast fusion. Cells Tissues Organs 176 (2004) 67-78
31. Moore R., and Walsh F.S. The cell adhesion molecule M-cadherin is specifically expressed in developing and regenerating, but not denervated skeletal muscle. Development 117 (1993) 1409-1420
32. Rose O., Rohwedel J., Reinhardt S., et al. Expression of M-cadherin protein in myogenic cells during prenatal mouse development and differentiation of embryonic stem cells in culture. Dev Dyn 201 (1994) 245-259
33. Cifuentes-Diaz C., Nicolet M., Alameddine H., et al. M-cadherin localization in developing adult and regenerating mouse skeletal muscle: possible involvement in secondary myogenesis. Mech Dev 50 (1995) 85-97
34. Brais B., Bouchard J.P., Xie Y.G., et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18 (1998) 164-167
35. Wang Q., and Bag J. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis. Biochem Biophys Res Commun 340 (2006) 815-822
36. Mizushima N., Yamamoto A., Matsui M., Yoshimori M., and Ohsumi Y. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15 (2004) 1101-1111
37. Nishino I. Autophagic vacuolar myopathies. Curr Neurol Neurosci Rep 3 (2003) 64-69
38. Tsuruta Y., Furuta A., Furuta K., Yamada T., Kira J., and Iwaki T. Expression of the lysosome-associated membrane proteins in myopathies with rimmed vacuoles. Acta Neuropathol 101 (2001) 579-584
39. Eskelinen E.L., Schmidt C.K., Neu S., et al. Disturbed cholesterol traffic but normal proteolytic function in LAMP-1/LAMP-2 double-deficient fibroblasts. Mol Biol Cell 15 (2004) 3132-3145
40. Peltonen L., Savukoski M., and Vesa J. Genetics of the neuronal ceroid lipofuscinoses. Curr Opin Genet Dev 10 (2000) 299-305